DC DiagnostiCare | Stock Discussion Forums

web analytics

web analytics

Gold/Mining/Energy | DC DiagnostiCare

Previous 10 | Next 10

To: Magpie who wrote (20)	6/17/1997 1:02:00 PM
From: Magpie	of 78

Found this news release today. I think the steady yet aggressive acquisition policy of this company will reward all who stick with it. I think it will move much faster when it gets it's TSE listing in September. Here is the release:- DC Diagnostic Inc. Provides Comparative Financial Results for the Period January 1 to March 31, 1997 EDMONTON, ALBERTA--DC DiagnostiCare Inc. provides expanded comparative financial results from operations for the period January 1 to March 31, 1997 as announced May 29, 1997. Service revenues for the 6 month period ended March 31, 1997, were $ 7,893,577 (annualized $15.8 million). Service revenues for the 3 months ended March 31, 1997, were $4,239,661 as compared to $3,653,916 for the 3 months ended December 31, 1996. Clinic operating costs before amortization and interest for the 6 month period ended March 31,1997 were $6,736,891, (annualized $13.5 million). Clinic operating costs before amortization and interest for the 3 months ended March 31, 1997, were $3,563,603 as compared to $3,173,288 for the 3 months ended December 31, 1996. For the 6 months ended March 31, 1997, cashflow from clinic operations before interest and amortization were $1,156,686(annualized $2.3 million). Head office operating costs were $547,188 (annualized $1.1 million) leaving $609,498 in cashflow before interest and amortization for the 6 months ended March 31,1997. For the 3 months ended March 31, 1997 cashflow from clinic operations before interest and amortization was $675,058 as compared to $480,628 for the 3 months ended December 31, 1996. Head office operating costs for the 3 months ended March 31, 1997 were $283,035 as compared to $264,153 for the 3 months ended December 31, 1996. Net cashflow before interest and amortization for the 3 months ended March 31, 1997, was $393,023 as compared to $216,475 for the 3 months ended December 31, 1996. Don Little, Chairman and CEO said "the increased market awareness of DiagnostiCare has generated a higher level of both acquisition and financing opportunities. We look forward to taking advantage of these opportunities to continue our revenue and profit growth during the fiscal period from April 1, 1997 to June 30, 1997. Quarterly results will be announced following that period." The ongoing activity on the acquisition side of DiagnostiCare continues to progress energetically. A total of 25 clinics are currently under negotiation with several near completion. All acquisitions are subject to the completion of definitive documentation and regulatory approval. DC DIAGNOSTICARE INC. Signed By: "Donald M. Cameron" VP Corporate Development and CFO

Share	Recommend \| Keep \| Reply \| Mark as Last Read

To: Graham Dellaire who wrote (28)	6/20/1997 3:01:00 AM
From: Magpie	of 78

Graham, A research document from McDermid St. Lawrence Securities Ltd. dated April 2, 1997 has a buy recommendation and a price of $2.79 to $3.12 by fiscal year end (September). Under the section called Highlights they report that "The company also plans to list on the TSE by the end of the current fiscal year". Another report by Groome Capital elaborates further saying that the company is seeking a TSE listing by fiscal year end to satisfy some conditions about special warrants issued to the Ontario Teachers Pension Fund. Interesting though that Groome Capital also sees a price of $3.00 to $3.50 by April 1998 providing DCE continues to achieve it's goals in 1997. A TSE listing may enhance its appeal to investors and funds who shun the more volatile VSE and ASE. I feel good about this one. Regards, Jim

Share	Recommend \| Keep \| Reply \| Mark as Last Read

To: Magpie who wrote (29)	8/13/1997 2:16:00 PM
From: RBMac	of 78

To all: PR Three Month Results DC DiagnostiCare Inc. Provides Comparative Financial Results for the Period April 1 to June 30, 1997 Business Wire - August 13, 1997 09:22 DC-DIAGNOSTICARE DCE. %NEW-YORK %MEDICINE %PHARMACEUTICAL %EARNINGS V%BW P%BW Jump to first matched term EDMONTON, Alberta--(BUSINESS WIRE)--Aug. 13, 1997--DC DiagnostiCare Inc. (VSE:DCE) provides expanded comparative financial results from operations for the period April 1 to June 30, 1997. Service revenues for the nine-month period ended June 30, 1997, were $13,064,391. Service revenues for the three months ended June 30, 1997 were $5,170,814 as compared to $4,239,661 for the three months ended March 31, 1997. Clinic operating costs before amortization and interest for the nine-month period ended June 30, 1997 were $10,870,301, or 83.2 percent of service revenues. Clinic operating costs before amortization and interest for the three months ended June 30, 1997 were $4,133,410 (79.9 percent of service revenues) as compared to $3,563,603 (84.1 percent of service revenues) for the three months ended March 31, 1997. For the nine months ended June 30, 1997, cashflow from clinic operations before interest and amortization was $2,194,090. Head office operating costs were $851,589 leaving $1,342,501 in cashflow before interest and amortization for the nine months ended June 30, 1997. For the three months ended June 30, 1997 cashflow from clinic operations before interest and amortization was $1,037,404 as compared to $676,058 for the three months ended March 31, 1997. Head office operating costs for the three months ended June 30, 1997 were $304,401 as compared to $283,035 for the three months ended March 31, 1997. Net cashflow before interest and amortization for the three months ended June 30, 1997 was $733,003 as compared to $393,023 for the three months ended March 31, 1997. Don Little, Chairman and CEO, said "New acquisitions and the realization of operating efficiencies are contributing significantly to the Company's profitability as planned. We look forward to taking advantage of further acquisition opportunities to continue our revenue and profit growth during the next quarter." A significant number of clinics are currently under negotiation with several near completion. All acquisitions are subject to the completion of definitive documentation and regulatory approval. Shares Outstanding: 12,570,920 Note to Editors: The Vancouver Stock Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this Press Release. CONTACT: DC DiagnostiCare Inc. Chuck Moser, 403/413-9715 diagnosticare.com

Share	Recommend \| Keep \| Reply \| Mark as Last Read

To: RBMac who wrote (30)	11/4/1997 4:59:00 PM
From: Michel Miron	of 78

NOVEMBER 4, 1997 DC DiagnostiCare Inc. to Complete $5,000,000 Financing EDMONTON, ALBERTA--DC DiagnostiCare Inc. (the "Company") is pleased to announce that it has entered into an agreement with Working Ventures Canadian Fund Inc. to complete the private placement of 2,083,333 Special Warrants at a price of $2.40 per Special Warrant, for aggregate gross proceeds of $5,000,000. Each Special Warrant will be exercisable into one common share of the Company (the "Common Share") and one-fifth of one share purchase warrant (collectively, the "Warrant"). The Warrants will be exercisable for a period of 18 months from the closing of the financing at a price of $3.00 per share. The Company has also agreed to use its best efforts to appoint an independent board member acceptable to the purchaser on or before April 4, 1998. In the event that the appointment is not completed by April 4, 1998, Special Warrants exercised thereafter will entitle the holder to receive units consisting of one Common Share and one quarter of one Warrant. In the event that the exercise of each Special Warrant is not qualified under a Prospectus by September 30, 1998, the Special Warrant will entitle the holder to receive one share and one third of one warrant. The Company has agreed to pay a placement fee to Yorkton Securities Inc. on the closing of the Private Placement in an amount equal to 3.0 percent of the aggregate subscription proceeds. Proceeds from the transaction will be used substantially for working capital and general corporate purposes. The proposed transaction is subject to a number of conditions including the approval of the Toronto and Vancouver Stock Exchanges. DC DIAGNOSTICARE INC. "Signed" Donald M. Cameron, VP Corporate Development and CFO -30-

Share	Recommend \| Keep \| Reply \| Mark as Last Read \| Read Replies (1)

To: RBMac who wrote (34)	3/17/1998 1:23:00 PM
From: RBMac	of 78

NEW PR - Is this going to dilute this stock significantly????? Or will they be able to absorb it? March 17, 1998 Underwriting Proceeds Of $15 Million Released To DiagnostiCare DC DIAGNOSTICARE INC ("DCE-TV;DCGOF-L") - Underwriting Proceeds Of $15 Million Released To DiagnostiCare Donald M. Cameron, VP Corporate Development and CFO of DC DiagnostiCare Inc. ("DiagnostiCare") is pleased to announce that DiagnostiCare has been issued final receipts by the Ontario, Alberta and British Columbia Securities Commissions for a prospectus qualifying the distribution of 10,897,436 common shares and 2,179,488 share purchase warrants on the exercise of previously issued special warrants. An aggregate of 512,821 of the share purchase warrants are exercisable at $2.43 per share on or before October 4, 1998 and the remaining 1,666,667 share purchase warrants are exercisable at $3.00 per share on or before May 6, 1999. With the obtaining of final receipts for its prospectus, underwriting proceeds of $15,000,000 previously held in escrow were released to DiagnostiCare. The funds were held in escrow pursuant to the terms of DiagnostiCare's Underwriting Agreement with Levesque Beaubien Geoffrion Inc. The prospectus qualifies securities issued by DiagnostiCare pursuant to three separate private placement transactions completed since April of last year, for aggregate gross proceeds of $25,000,000. The funds will be utilized by DiagnostiCare to continue the funding of its clinic acquisition program. DiagnostiCare's business strategy is to capitalize on the fragmented medical imaging market in Canada by acquiring existing diagnostic clinics. Through the implementation of cost-saving measures derived from economies of scale and professional management, DiagnostiCare is able to capture increased returns on its investment in such clinics, while at the same time continuing to provide efficient, professional services to its clients. Since going public in July 1996 DiagnostiCare has acquired 57 clinics and has opened three additional specialty diagnostic imaging clinics. Donald Little, DiagnostiCare's Chairman and Chief Executive Officer, commented "We are thrilled with the level of institutional support that we have received in completing financings for $25 million over the past year. Our investors see the enormous potential that comes from being the leading consolidator in an otherwise fragmented market. Our acquisition team now has sufficient resources to aggressively pursue our nation-wide growth strategy." TEL: (403) 413-9715 Chuck Moser, Director Investor Relations FAX: (403) 413-8916 DC DiagnostiCare Inc. Internet: diagnosticare.com

Share	Recommend \| Keep \| Reply \| Mark as Last Read \| Read Replies (2)

Previous 10 | Next 10

Copyright/IP Policy

Copyright © 1995-2013 Knight Sac Media. All rights reserved.